[Technical aspects and surgical strategy for removal of corticotroph pituitary adenoma].
The development of transsphenoidal microsurgery and the refinement of endocrinological and radiological diagnostic procedures have afforded therapeutic options appropriate for each individual case in patients with pituitary-dependent hypercortisolism. Compared with other secreting pituitary tumors, the corticotroph adenoma seems to be the most biologically active tumor. Clinical evidence of hypercortisolism mainly occurs at an early stage of tumor growth when the tumor is very small, below the detection threshold of modern imaging techniques. While the treatment of large tumors remains difficult due to the non-discrete boundary lines of the tumor and extension or invasion, surgical removal of very tiny tumors requires reliable preoperative or peroperative identification in order to achieve total tumor resection for clinical remission and pituitary preservation to prevent hypopituitarism. We reviewed all the current surgical techniques or clever surgical procedures used to achieve both goals with the lowest complication rate. We report here the state-of-the-art of surgical management of corticotroph pituitary adenoma focusing on preoperative radiological and biological data required for performing guided intrasellar surgical exploration and reliable tumor identification. Different technical aspects of the nasosphenoidal approaches are reported as well as the modified transdiaphragmatic or transtubercular transcisternal approaches to tumors in a suprasellar localization or lying along the pituitary stalk. The advantages of minimally invasive surgical techniques such as intrasellar endoscopic surgery are discussed. Adapted surgical techniques for second transnasal surgery indicated for recurrent tumors are described. Guidelines are given for peroperative tumor identification with macroscopic assessment or histological control with frozen section biopsies. Different techniques for tumor removal are discussed from selective microadenomectomy to enlarged pituitary resection and total hypophysectomy. Methods for preoperative guidance of total tumor removal are proposed including histological or biological assessment of normal adjacent pituitary tissue. the strategy of surgical intrasellar exploration and tumor resection is outlined using a set of algorithms. The first is devoted to positive preoperative documentation of the tumor. The second is proposed for the surgical scenario where there is no preoperative MRI evidence of the tumor. Special strategies are discussed for ectopic adenoma or multiple tumors. Revision surgical management after surgical failure or tumor recurrence is described. Special guidelines for surgical treatment of large clinically silent corticotroph macroadenomas are given with emphasis on the high risk of recurrence in comparison with other silent pituitary tumors such as gonadotroph or immunonegative adenomas.
Perrin
G
G
Service de Neurochirurgie A, Hôpital Neurologique et Neurochirurgical Pierre-Wertheimer, BP Lyon-Montchat, 69394 Lyon Cedex 3, France. gilles.perrin@chu-lyon.fr
Stevenaert
A
A
Jouanneau
E
E
D000182:ACTH Syndrome, Ectopic / Q000150:complications / Q000601:surgery; D000236:Adenoma / Q000150:complications / Q000378:metabolism / Q000601:surgery*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000209:etiology / Q000601:surgery*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy / Q000209:etiology; D003952:Diagnostic Imaging; D004724:Endoscopy; D006801:Humans; D007016:Hypophysectomy / Q000295:instrumentation / Q000379:methods*; D008279:Magnetic Resonance Imaging; D017591:Petrosal Sinus Sampling; D010911:Pituitary Neoplasms / Q000150:complications / Q000378:metabolism / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control; D011292:Premedication; D012086:Reoperation
D000900:Anti-Bacterial Agents; D000324:Adrenocorticotropic Hormone; D003894:Deamino Arginine Vasopressin; D003348:Cortisone
Aspects techniques et conduite de l'exérèse de l'adénome hypophysaire corticotrope.